Antioxidants (2020) 9:367
Idorn T, Knop FK, Jrgensen MB, Jensen T, Resuli M, Hansen PM et al (2016) Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, placebo-controlled, double-blind, parallel-group
Persistent or worsening symptoms should be discussed with a healthcare provider
What it means: Your tactile sensory neurons have a lowered activation threshold
GLP-1 receptor activation suppresses appetite by slowing gastric emptying, increasing central satiety signalling in the hypothalamus, and triggering glucose-dependent insulin secretion from pancreatic beta cells [1]
If a provider pushes you toward more expensive plans without medical justification, that is a business decision, not a clinical one